You are here: Home » Companies » News
Business Standard

Govt bars Abbott from withdrawing stent to maintain uninterrupted supply

Last month Abbott globally withdrew its bioresorbable stent Absorb citing commercial reasons

Aneesh Phadnis  |  Mumbai 


The  Department of Pharmaceuticals (DoP) has barred maker from withdrawing its Xience Alpine coronary stent from the market. The government move comes following its directive to to maintain an uninterrupted supply of stents.

The order effectively sets aside the National Pharmaceutical Pricing Authority's (NPPA) decision to allow to withdraw the Xience Alpine stent for commercial reasons. In an order earlier this week the allowed to withdraw the stent over one-year period after issuing a public notice for the same.

In its office memorandum on Friday, said that it had on Wednesday invoked powers under section 3 of the Price Order of 2013 and directed manufacturing to maintain uninterrupted supply for three months from the date of notification.

said that its Thursday's order supersedes the decision earlier this week and makes it null and void. has also been directed to submit a weekly report on produced and distributed and also submit a weekly production plan to the and Controller General of India.

did not immediately comment on the order.

Last month globally withdrew its bioresorbable stent Absorb citing commercial reasons.

First Published: Fri, September 29 2017. 21:59 IST